Amarin Corp. Plc
(NASDAQ : AMRN)

( )
AMRN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 2.25%93.515.5%$179.67m
VRXValeant Pharmaceuticals International, Inc. 0.13%30.3014.1%$178.29m
ICLRICON plc 4.47%205.204.2%$131.92m
CTLTCatalent, Inc. 1.02%111.032.1%$128.45m
GWPHGW Pharmaceuticals Plc 0.21%218.816.1%$124.34m
BHCBausch Health Cos., Inc. 0.13%30.300.0%$108.60m
UTHRUnited Therapeutics Corp. -0.55%201.6714.1%$97.68m
JAZZJazz Pharmaceuticals Plc 1.21%168.392.3%$90.22m
SAVACassava Sciences, Inc. -1.63%35.090.0%$67.46m
ARGXargenx SE 1.72%277.470.0%$51.25m
PRGOPerrigo Co. Plc 1.94%41.176.9%$37.55m
SAGESAGE Therapeutics, Inc. -0.23%75.507.6%$37.53m
AMRNAmarin Corp. Plc -1.96%5.011.5%$29.35m
PCRXPacira Biosciences, Inc. -4.45%66.349.9%$27.57m
ICPTIntercept Pharmaceuticals, Inc. -4.02%20.5516.8%$22.11m

Company Profile

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.